World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
16387
World Ranking
2012
National Ranking
24

Overview

Jan Poolman is a researcher affiliated with Janssen in Belgium whose work primarily intersects the fields of biochemistry, genetics, molecular biology, and medicine. Their research spans multiple subfields, including endocrinology, epidemiology, molecular medicine, molecular biology, and infectious diseases.

The scientist has contributed extensively to topics related to Escherichia coli research studies, antibiotic resistance in bacteria, and urinary tract infection management. Other notable research areas include gut microbiota and health, enterobacteriaceae and Cronobacter research, bacterial infections and vaccines, and bacterial identification and susceptibility testing.

Jan Poolman has published several papers, reflecting the focus and progression of their scientific inquiries. Recent selected publications include:

  • "Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review," 2020, Clinical Infectious Diseases
  • "Genomics and pathotypes of the many faces of Escherichia coli," 2022, FEMS Microbiology Reviews
  • "Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines," 2021, npj Vaccines
  • "Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections," 2020, npj Vaccines
  • "Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies," 2022, Clinical Infectious Diseases

Frequent collaboration has been a feature of Poolman's career, working notably with coauthors such as Jeroen Geurtsen, Bart Spiessens, Oscar Go, Marc J. M. Bonten, and Michal Sarnecki.

Their research findings have been disseminated particularly in journals like Open Forum Infectious Diseases, npj Vaccines, Clinical Infectious Diseases, Vaccine, and The Journal of Urology. These venues have hosted multiple publications by Poolman, highlighting an ongoing engagement with infectious disease research and vaccine development.

Best Publications

  • Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

    Roman Prymula;Pascal Peeters;Viktor Chrobok;Pavla Kriz

  • Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

    Carl E. Frasch;Wendell D. Zollinger;Jan T. Poolman

  • Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.

    Jordan W. Tappero;Rosanna Lagos;Aurora Maldonado Ballesteros;Brian Plikaytis

  • Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies

    Hussein Abdillahi;Jan T. Poolman

  • Description and nomenclature of Neisseria meningitidis capsule locus.

    Odile B. Harrison;Heike Claus;Ying Jiang;Julia S. Bennett

  • Glycoconjugate vaccines and immune interference: A review

    Ron Dagan;Jan Poolman;Claire-Anne Siegrist

  • Extraintestinal Pathogenic Escherichia Coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

    Jan T. Poolman;Michael Wacker

  • Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review.

    Marc Bonten;James R Johnson;Anita H J van den Biggelaar;Leonidas Georgalis

  • Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.

    R. Borrow;G.M. Carlone;N. Rosenstein;M. Blake

  • Point mutation in meningococcal por A gene associated with increased endemic disease.

    B.T. McGuinness;I.N. Clarke;P.R. Lambden;A.K. Barlow

  • Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

    Keith Cartwright;Rhonwen Morris;Hans Rümke;Andrew Fox

  • Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

    Angela Csaki Huttner;Christoph Hatz;Christoph Hatz;Germie van den Dobbelsteen;Darren Abbanat

  • Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines.

    C. C. A. M. Peeters;A.-M. Tenbergen-Meekes;J. T. Poolman;M. Beurret

  • Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China.

    J F Wang;D A Caugant;X Li;X Hu

  • Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay.

    K. Saukkonen;M. Leinonen;H. Abdillahi;J.T. Poolman

  • Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines

    Jan Poolman;Raymond Borrow

  • Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA

    Abiodun David Ogunniyi;Matthew C. Woodrow;Jan T. Poolman;James C. Paton

  • Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development.

    Kirsi Saukkonen;Hussein Abdillahi;Jan T. Poolman;Maija Leinonen

  • Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA.

    Hussein Abdillahi;Jan T. Poolman

  • Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.

    Brian McGuinness;Ann K. Barlow;Ian N. Clarke;John E. Farley

  • Heterogeneity in Diphtheria-Tetanus–Acellular Pertussis Vaccine–Specific Cellular Immunity during Infancy: Relationship to Variations in the Kinetics of Postnatal Maturation of Systemic Th1 Function

    J. Rowe;C. Macaubas;T. Monger;B.J. Holt

Frequent Co-Authors

Helena Käyhty
Helena Käyhty Finnish Institute for Health and Welfare (THL)
Lode Schuerman
Lode Schuerman GlaxoSmithKline (United Kingdom)
J. H. Van Boom
J. H. Van Boom Leiden University
G. A. Van Der Marel
G. A. Van Der Marel Leiden University
C. A. A. Van Boeckel
C. A. A. Van Boeckel Leiden University
Jan Tommassen
Jan Tommassen Utrecht University
Emmanuel J. H. J. Wiertz
Emmanuel J. H. J. Wiertz Utrecht University
Ger T. Rijkers
Ger T. Rijkers University College Roosevelt
Marc J. M. Bonten
Marc J. M. Bonten Utrecht University
Mark Achtman
Mark Achtman University of Warwick

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in combining immunology with healthcare, pursuing nursing degrees can be a strategic move. Many students explore the best online rn programs for non nurses to transition into nursing without a prior background. These online RN programs offer flexibility and a pathway to essential clinical roles.

Accelerated options are also popular for students seeking a faster route. Exploring accelerated nursing programs can help students obtain a Bachelor of Science in Nursing in a shorter time, enabling rapid entry into the nursing workforce while applying immunology knowledge practically.

For those looking for foundational licensure with quicker access into the workforce, accredited lpn programs easy to get into are an attractive option. These programs provide essential nursing skills making graduates valuable in various healthcare settings, where immunological expertise is increasingly relevant.

Finally, professionals aiming for advanced practice roles should consider the easiest online nurse practitioner programs. These degree pathways empower nurses to deliver specialized care, often incorporating immunological principles, and open doors to leadership roles in healthcare.

Best Scientists Citing Jan Poolman

Trending Scientists

Recently Published Articles